Adrenocortical carcinoma: review and update

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Adrenocortical carcinoma is a rare endocrine malignancy with a poor prognosis.
• Diagnostic challenges exist, necessitating refined algorithms and criteria, particularly for myxoid and oncocytic variants.
• Pediatric adrenocortical carcinomas pose unique diagnostic difficulties due to differing malignancy indicators compared to adults.

Purpose of the Study:

• To highlight diagnostic challenges in adrenocortical carcinoma, including specific variants and pediatric cases.
• To explore the utility of gene expression profiling in differentiating adrenocortical tumors and establishing prognostic groups.
• To underscore the importance of understanding pathogenesis for developing novel therapeutic strategies.

Main Methods:

• Review of diagnostic criteria for adrenocortical carcinoma, including special variants.
• Analysis of gene expression profiling via transcriptome analysis.
• Consideration of pediatric versus adult adrenocortical carcinoma presentations.

Main Results:

• Transcriptome analysis can effectively discriminate adrenocortical carcinomas from adenomas.
• Gene expression profiling can stratify adrenocortical carcinomas into distinct prognostic groups.
• Specific variants like myxoid and oncocytic require distinct diagnostic considerations.

Conclusions:

• Accurate diagnosis of adrenocortical carcinoma is crucial, with special attention to variants and age-specific features.
• Gene expression profiling offers a powerful tool for tumor classification and prognosis.
• Further understanding of adrenocortical carcinoma pathogenesis is key to identifying future treatment targets.